Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥1,725 JPY
Change Today +16.00 / 0.94%
Volume 61.2K
As of 2:00 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for taiko pharmaceutical co ltd (4574)

This company's debt to total capital ratio, at 14.76%, is in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 81.53 days worth of sales outstanding. Last, Taiko Pharmaceutical Co., Ltd. is among the most efficient in its industry at managing inventories, with only 338.27 days of its Cost of Goods Sold tied up in inventory.
View Balance Sheet In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
Mar 31
Mar 31
Mar 31
4 Year
Cash and Equivalents4,661.05,173.08,543.06,119.0
TOTAL CASH AND SHORT TERM INVESTMENTS4,661.05,173.08,543.06,119.0
Accounts Receivable2,425.02,619.02,160.01,851.0
TOTAL RECEIVABLES2,425.02,619.02,160.01,851.0
Deferred Tax Assets, Current196.0210.0350.0195.0
Other Current Assets78.074.0143.0133.0
TOTAL CURRENT ASSETS8,712.09,474.012,901.010,478.0
NET PROPERTY PLANT AND EQUIPMENT2,862.02,799.02,856.07,627.0
Long-Term Investments485.0569.0705.0369.0
Deferred Tax Assets, Long Term141.0132.0124.092.0
Other Intangibles59.
Other Long-Term Assets2.0--2.02.0
TOTAL ASSETS12,261.013,016.016,622.018,599.0
Accounts Payable387.0444.0496.0349.0
Accrued Expenses316.0269.0364.093.0
Short-Term Borrowings------2,110.0
Current Portion of Long-Term Debt/Capital Lease17.
Current Portion of Capital Lease Obligations17.
Current Income Taxes Payable1,190.01,330.02,653.02,036.0
Other Current Liabilities, Total495.0443.0621.0402.0
TOTAL CURRENT LIABILITIES2,405.02,502.04,147.05,003.0
Capital Leases21.
Pension & Other Post-Retirement Benefits484.0460.0478.0522.0
Other Non-Current Liabilities568.0563.0565.0566.0
TOTAL LIABILITIES3,478.03,537.05,217.06,127.0
Common Stock155.0178.0286.0364.0
Additional Paid in Capital66.089.0197.0275.0
Retained Earnings8,630.09,473.011,030.012,475.0
Treasury Stock---281.0-281.0-921.0
Comprehensive Income and Other-68.020.0173.0279.0
TOTAL COMMON EQUITY8,783.09,479.011,405.012,472.0
TOTAL EQUITY8,783.09,479.011,405.012,472.0
TOTAL LIABILITIES AND EQUITY12,261.013,016.016,622.018,599.0

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4574:JP ¥1,725.00 JPY +16.00

4574 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4574.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4574 Industry Range
Price/Earnings 15.0x
Price/Sales 2.5x
Price/Book 1.8x
Price/Cash Flow 15.5x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIKO PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at